I am sure this has been discussed before, so my apologies in advance.

In Phase 3 trials similar to BETonMACE (diabetic with cardio vascular issues), what was the MACE rate for the placebo group?  And if we were to extrapolate to the 1200 placebo patients with median 24 months, what does that imply in terms of # of MACE events for the placebo group in BETonMACE?

Thanks a lot!